Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674119010 | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3674121017 | Benzocaine 10 mg and cetylpyridinium chloride 1.4 mg oromucosal lozenge | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46761001000001110 | Benzocaine 10mg / Cetylpyridinium chloride 1.4mg lozenges | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Compound anesthetic topical preparation | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Local anesthetic | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing cetylpyridinium | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing benzocaine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Cetylpyridinium | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Cationic surfactant | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Skin anti-infective | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Local anti-infective | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing benzocaine and cetylpyridinium | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing cetylpyridinium in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing benzocaine in oropharyngeal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Conventional release oromucosal lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product manufactured as oromucosal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has precise active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength denominator unit | Lozenge | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength numerator value | 1.4 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength denominator unit | Lozenge | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has basis of strength substance | Cetylpyridinium chloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has unit of presentation | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has precise active ingredient | Cetylpyridinium chloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has basis of strength substance | Benzocaine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Product containing only benzocaine and cetylpyridinium in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Cetylpyridinium | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has unit of presentation | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Conventional release oromucosal lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oromucosal route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | lozenge.oromucosal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Cetylpyridinium chloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Conventional release oromucosal lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has unit of presentation | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has unit of presentation | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Conventional release oromucosal lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Benzocaine + Cetylpyridinium | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has active ingredient | Cetylpyridinium chloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has manufactured dose form | Lozenge | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has specific active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has specific active ingredient | Cetylpyridinium chloride | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Has dispensed dose form | Lozenge | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Benzocaine+cetylpyridinium chloride 10mg/1.4mg lozenge - product | Is a | False | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Inferred relationship | Existential restriction modifier | |
Merocaine lozenges (SSL International Plc) | Is a | True | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Inferred relationship | Existential restriction modifier | |
Benzocaine 10mg / Cetylpyridinium chloride 1.4mg lozenges 24 lozenge | Is pack of | False | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Inferred relationship | Existential restriction modifier | |
Benzocaine 10mg / Cetylpyridinium chloride 1.4mg lozenges 24 lozenge | Has VMP | True | Product containing precisely benzocaine 10 milligram and cetylpyridinium chloride 1.4 milligram/1 each conventional release oromucosal lozenge | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets